DR. MICHAEL WILLIAM SMITH M.D. NPI 1205871035

NPI Details

DR. Michael William Smith, M.D. is a rheumatology internal medicine in Kansas City, MO with 21 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Michael William Smith, M.D. NPI is 1205871035. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4440 BROADWAY BLVD STE 40
KANSAS CITY, MO
ZIP 64111-315
Phone: (816) 531-0930
Fax: (816) 753-2671

The NPI 1205871035 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood creatinine level (HCPCS:82565)
• Liver function blood test panel (HCPCS:80076)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Urinalysis, manual test (HCPCS:81002)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 6/17/2006 and was last updated on 3/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: